mkdir -p /home/daytona/workspace/anki-cards && cat > /home/daytona/workspace/anki-cards/cell_death_pathology.txt << 'ANKIEOF' Cell Death Pathology (Necrosis, Apoptosis, Necroptosis, Ferroptosis, Autophagy) - NEET PG 2026 <b>NECROSIS</b><br><br><b>Definition and Mechanism:</b> Necrosis is a pathologic (always abnormal) process resulting from severe irreversible cell injury. Key causes: ischemia, microbial toxins, burns, chemical/physical injury, pancreatitis (leaked proteases). Irreversibility is defined by two features: (1) inability to reverse mitochondrial dysfunction (failure of oxidative phosphorylation and ATP generation) even after the original injury resolves, and (2) profound disturbances in membrane function. Cellular membranes fall apart, lysosomal enzymes leak out and digest the cell, and an inflammatory reaction is induced by DAMPs (damage-associated molecular patterns) - including ATP from damaged mitochondria and uric acid from DNA breakdown - recognized by macrophage receptors, triggering cytokine-mediated inflammation and phagocytosis of debris.<br><br><b>Morphology of Necrosis (H&amp;E):</b> Cytoplasm: increased eosinophilia (denatured proteins bind eosin, loss of basophilic RNA), glassy homogeneous appearance (loss of glycogen), vacuolated moth-eaten cytoplasm (organelle digestion), myelin figures (phospholipid whorls). Nucleus: THREE patterns - (1) Pyknosis: nuclear shrinkage with dark basophilic condensed chromatin, (2) Karyorrhexis: fragmentation of pyknotic nucleus, (3) Karyolysis: fading of basophilia due to DNase digestion of DNA - nucleus dissolves in 1-2 days. Electron microscopy: discontinuities in plasma and organelle membranes, marked mitochondrial dilation with amorphous intramitochondrial densities, disrupted lysosomes, myelin figures. Fate: necrotic cells may be phagocytosed by leukocytes or persist and become calcified (dystrophic calcification).<br><br><b>Morphologic Patterns of Tissue Necrosis:</b><br><br><b>1. Coagulative Necrosis:</b> Tissue architecture preserved for days after injury. Firm texture. Injury denatures structural proteins AND enzymes, limiting proteolysis. H&amp;E: eosinophilic anucleate ghost cells (cell outlines preserved). Occurs in infarcts of ALL solid organs EXCEPT the brain. Most common pattern overall. Example: myocardial infarct, renal infarct.<br><br><b>2. Liquefactive Necrosis:</b> Complete digestion of dead cells, transforming tissue into viscous liquid, eventually removed by phagocytes. Seen in: (a) bacterial/fungal infections - leukocyte enzymes liquefy tissue, creamy yellow pus in abscess, (b) CNS hypoxic injury (brain infarct) - for unknown reasons, ischemia in brain causes liquefactive necrosis. Tissue architecture obliterated, no cell outlines.<br><br><b>3. Caseous Necrosis:</b> Cheese-like (Latin: caseus), friable yellow-white appearance. Encountered most often in TUBERCULOSIS. H&amp;E: structureless collection of amorphous granular pink cellular debris - tissue architecture completely obliterated, no cell outlines discernible. Surrounded by epithelioid macrophages and other inflammatory cells forming a GRANULOMA. Also seen in histoplasmosis and some fungal infections.<br><br><b>4. Fat Necrosis:</b> Focal areas of fat destruction. Caused by: (a) acute pancreatitis - activated pancreatic lipases leak from damaged acinar cells, liquefy fat cell membranes, release triglycerides, fatty acids combine with calcium to form chalky white saponification deposits (dystrophic calcification). H&amp;E: shadowy outlines of necrotic fat cells with granular basophilic calcium deposits and inflammatory reaction. Also: abdominal trauma, breast fat necrosis.<br><br><b>5. Fibrinoid Necrosis:</b> Special form visible only by LIGHT MICROSCOPY. Seen in: immune complex vasculitis (antigen-antibody complexes deposited in vessel walls) and severe hypertension. H&amp;E: bright pink (fibrin-like) amorphous material in vessel walls. Seen in polyarteritis nodosa, transplant rejection, malignant hypertension.<br><br><b>6. Gangrenous Necrosis:</b> NOT a distinct pattern - clinical term. Usually refers to a limb (generally lower leg) that lost blood supply, undergone coagulative necrosis involving multiple tissue layers. Dry gangrene: coagulative necrosis without infection. Wet gangrene: superimposed bacterial infection causes liquefactive component (leukocyte and bacterial enzyme action). Gas gangrene: Clostridium infection.<br><br><b>Clinical Significance of Necrosis (Biomarkers):</b> Necrosis-associated leakage of tissue-specific proteins into blood: cardiac troponin (myocardial necrosis, detectable within 2 hours), transaminases (hepatocyte necrosis), alkaline phosphatase-specific isoform (bile duct epithelium necrosis).<br><br><b>APOPTOSIS</b><br><br><b>Definition:</b> Programmed, regulated cell death - cells activate intrinsic enzymes (caspases) that degrade their own nuclear DNA and nuclear and cytoplasmic proteins. First described in 1972 (Kerr, Wyllie, and Currie). Name means "falling off" in Greek (like leaves falling from a tree). Key feature: plasma membrane REMAINS INTACT throughout - apoptotic bodies are membrane-bound fragments rapidly phagocytosed before contents leak out, so NO INFLAMMATORY REACTION is elicited. Process of phagocytosis of apoptotic cells called EFFEROCYTOSIS.<br><br><b>Physiological Examples of Apoptosis:</b> (1) Embryogenesis - organ and tissue formation, developmental sculpting (e.g., interdigital web removal), (2) Involution of hormone-dependent tissues (endometrium after menstrual cycle, lactating breast after weaning), (3) Turnover of proliferative tissues (intestinal epithelium, lymphocytes in lymph nodes and thymus), (4) Elimination of excess leukocytes at end of immune/inflammatory responses, (5) Elimination of self-reactive lymphocytes (clonal deletion in thymus - central tolerance), (6) Elimination of B cells in germinal centers that fail to produce high-affinity antibodies.<br><br><b>Pathological Examples of Apoptosis:</b> (1) DNA damage (radiation, cytotoxic chemotherapy) - activation of pro-apoptotic BH3-only proteins, (2) Accumulation of misfolded proteins (ER stress) - BH3-only protein activation, (3) Viral infections - viral proteins activate pro-apoptotic proteins or caspases, (4) Cell killing by cytotoxic T lymphocytes (CTLs) - activate caspases in target cells, (5) Atrophy of parenchymal organs after duct obstruction, (6) Progressive cell loss in neurodegenerative diseases (Alzheimer, Parkinson).<br><br><b>Morphology of Apoptosis:</b> (1) Cell shrinkage (cell volume reduced), dense eosinophilic cytoplasm, (2) Chromatin condensation (pyknosis) - crescent-shaped condensed chromatin masses at nuclear periphery, (3) Membrane blebbing - cytoplasmic protuberances, (4) Fragmentation into APOPTOTIC BODIES (membrane-bound fragments containing cytoplasm and nuclear material), (5) Phagocytosis of apoptotic bodies by macrophages and neighboring cells (efferocytosis) - NO inflammation, (6) Phosphatidylserine flips from inner to outer leaflet of plasma membrane - serves as "eat me" signal for macrophage receptors, (7) Secretion of "find me" signals (chemotactic factors) that recruit phagocytes.<br><br><b>Mechanism and Phases of Apoptosis:</b> Two phases: (1) INITIATION PHASE - caspases become catalytically active, (2) EXECUTION PHASE - terminal caspases trigger cellular fragmentation. Key enzymes: CASPASES - cysteine proteases that cleave proteins after aspartic acid residues. Exist as inactive PROENZYMES that require enzymatic cleavage to become active. Active caspases are a marker for apoptosis. Initiator caspases: caspase-8 (extrinsic), caspase-9 (intrinsic). Executioner caspases: caspase-3, caspase-6, caspase-7.<br><br><b>Intrinsic (Mitochondrial) Pathway of Apoptosis:</b> Responsible for MOST physiologic and pathologic apoptosis. Triggered by: loss of survival signals, DNA damage, accumulation of misfolded proteins (ER stress). BCL-2 family is the master regulator: ANTI-APOPTOTIC members (BCL-2, BCL-XL, MCL-1) - have BH1-4 domains, reside in outer mitochondrial membrane, prevent cytochrome c leakage. PRO-APOPTOTIC members (BAX, BAK) - have BH1-3 domains, oligomerize and form channels in outer mitochondrial membrane allowing cytochrome c leakage. BH3-ONLY proteins (BAD, BIM, BID, PUMA, NOXA) - sensors of cellular stress, contain only BH3 domain, activated by DNA damage and ER stress, directly activate BAX-BAK and also inhibit BCL-2-BCL-XL. Sequence: BH3-only proteins activated - BAX-BAK oligomerize in mitochondrial membrane - cytochrome c leaks into cytoplasm - cytochrome c binds APAF-1 - forms APOPTOSOME (multimeric complex) - binds and activates caspase-9 (initiator caspase) - caspase-9 activates caspase-3 (executioner caspase) - cell fragmentation and death. Also: Smac/DIABLO released from mitochondria, neutralizes IAPs (inhibitor of apoptosis proteins), permitting caspase cascade. BCL-2 is proto-oncogene in B cell lymphomas (t(14:18) translocation).<br><br><b>Extrinsic (Death Receptor) Pathway of Apoptosis:</b> Initiated by engagement of DEATH RECEPTORS on cell surface - members of TNF receptor family with cytoplasmic DEATH DOMAIN. Prototype death receptors: (1) Fas (CD95) + FasL (FasL expressed on T cells recognizing self-antigens and CTLs), (2) TNFR1 (type 1 TNF receptor). Mechanism of Fas pathway: FasL binds Fas - 3+ Fas molecules cluster - death domains bind adaptor protein FADD (Fas-associated death domain) - FADD recruits inactive caspase-8 (or caspase-10) - multiple caspase-8 molecules undergo autocatalytic cleavage - active caspase-8 activates executioner caspases (caspase-3). Inhibitor: FLIP protein binds pro-caspase-8, blocks FADD binding (produced by some viruses and normal cells). Functions: eliminates self-reactive lymphocytes, CTL killing of virus-infected and tumor cells. Cross-talk: in hepatocytes, caspase-8 from extrinsic pathway cleaves BID (BH3-only protein) to form truncated BID (tBID), which activates BAX-BAK (amplifying via intrinsic pathway).<br><br><b>Regulators of Apoptosis:</b> Pro-apoptotic: p53 (upregulates PUMA, BAX), BH3-only proteins (BAD, BIM, BID, PUMA, NOXA), BAX, BAK, Fas, FasL, TNF, cytochrome c, APAF-1, caspases. Anti-apoptotic: BCL-2, BCL-XL, MCL-1 (growth factor-induced), IAPs (inhibitors of apoptosis - block caspase-3-7), FLIP (blocks caspase-8), survivin. p53 role: after DNA damage, p53 accumulates and transcribes PUMA and BAX - promotes mitochondrial pathway apoptosis. If p53 is mutated, cells with damaged DNA survive and may become cancerous.<br><br><b>NECROSIS vs. APOPTOSIS (Key Comparison Table):</b> Size of cell: necrosis = enlarged (swelling), apoptosis = reduced (shrinkage). Nucleus: necrosis = pyknosis-karyorrhexis-karyolysis, apoptosis = fragmentation into nucleosome-sized fragments. Plasma membrane: necrosis = disrupted, apoptosis = intact but altered (phosphatidylserine externalized). Cellular contents: necrosis = enzymatic digestion, may leak out, apoptosis = intact - released in membrane-bound fragments. Adjacent inflammation: necrosis = FREQUENT (due to leakage of DAMPs and cell contents), apoptosis = NO (contents sequestered in intact membranes). Physiologic or pathologic: necrosis = invariably pathologic, apoptosis = often physiologic (may be pathologic). Mechanism: necrosis = passive (no energy required), apoptosis = active (energy-dependent, programmed). Caspases: necrosis = absent, apoptosis = activated (key mediators). BCL-2 family: necrosis = not involved in mechanism, apoptosis = central regulators. DNA: necrosis = random degradation, apoptosis = internucleosomal cleavage (ladder pattern on gel). Reversibility: necrosis = irreversible, apoptosis = can be blocked if early.<br><br><b>NECROPTOSIS</b><br><br><b>Definition:</b> Programmed necrosis - a hybrid form sharing features of both necrosis (morphology) and apoptosis (genetically regulated). Sometimes called "caspase-independent programmed cell death." Morphologically resembles necrosis: loss of ATP, cell and organelle swelling, ROS generation, lysosomal enzyme release, plasma membrane rupture with release of cellular contents causing inflammation.<br><br><b>Mechanism:</b> Triggered by: TNFR1 ligation (most studied), Fas ligation, sensors of viral RNA/DNA. Caspase-INDEPENDENT (in contrast to apoptosis). Key molecules: RIPK1 (receptor-interacting protein kinase 1) and RIPK3 form a multiprotein complex. RIPK3 phosphorylates MLKL (mixed-lineage kinase domain-like protein). Phosphorylated MLKL monomers oligomerize, translocate to plasma membrane, and form PORES causing plasma membrane disruption (necrosis-like rupture). When caspase-8 is ACTIVE: TNFR1 ligation leads to apoptosis. When caspase-8 is INACTIVE (inhibited): TNFR1 ligation leads to necroptosis via RIPK1-RIPK3-MLKL pathway. This explains why some viruses that encode caspase inhibitors (e.g., cytomegalovirus) trigger necroptosis as a host defense backup.<br><br><b>Physiologic and Pathologic Roles of Necroptosis:</b> Physiologic: formation of mammalian bone growth plate. Pathologic: steatohepatitis, acute pancreatitis, ischemia-reperfusion injury, neurodegenerative diseases (Parkinson disease), anti-viral defense against viruses encoding caspase inhibitors (CMV). KEY DIFFERENCES from apoptosis: caspase-independent, cell swells and ruptures, causes inflammation (like necrosis), triggered by programmed signaling (like apoptosis).<br><br><b>FERROPTOSIS</b><br><br><b>Definition:</b> Iron-dependent, regulated form of cell death triggered when excessive intracellular iron or ROS overwhelm glutathione-dependent antioxidant defenses, causing unchecked LIPID PEROXIDATION. Not apoptosis, not classical necrosis - a distinct regulated cell death pathway. Name derived from Latin ferrum (iron).<br><br><b>Mechanism:</b> Iron catalyzes ROS production (Fenton reaction). Excessive lipid peroxidation disrupts membrane fluidity, lipid-protein interactions, ion and nutrient transport, and signaling pathways. Loss of plasma membrane permeability leads to cell death resembling necrosis. Can be PREVENTED by reducing iron levels or by antioxidants (GPX4 - glutathione peroxidase 4 - is the key protective enzyme). Key distinguishing feature: ultrastructurally, loss of mitochondrial cristae and ruptured outer mitochondrial membrane (distinct from apoptosis and classic necrosis).<br><br><b>Associations:</b> Cancer cell death, neurodegenerative diseases, stroke, ischemia-reperfusion injury. Role in normal development and physiology remains controversial. Unlike classical necrosis, the process is regulated by specific signals and can be pharmacologically prevented. GPX4 inhibitors (e.g., RSL3) induce ferroptosis in cancer cells (therapeutic interest).<br><br><b>AUTOPHAGY</b><br><br><b>Definition:</b> Self-eating (Greek: auto=self, phag=eating). Lysosomal digestion of the cell's own components. A survival mechanism during nutrient deprivation (cell cannibalizes itself, recycles contents for nutrients and energy). Also a fundamental stress response in physiologic states (aging, exercise) and pathologic processes (hypoxia, oxidative stress, organelle damage).<br><br><b>Steps of Autophagy:</b> (1) NUCLEATION - formation of isolation membrane (PHAGOPHORE) derived from ER (other sources: plasma membrane, mitochondria), (2) ELONGATION - phagophore expands to surround cytoplasmic materials including organelles, (3) AUTOPHAGOSOME FORMATION - double-membrane-bound vesicle that sequesters intracellular organelles and cytosolic structures, (4) MATURATION - autophagosome fuses with LYSOSOME to form AUTOPHAGOLYSOSOME, (5) DEGRADATION - lysosomal enzymes digest enclosed contents, products recycled as metabolites.<br><br><b>Key Molecules:</b> ATG proteins (autophagy-related genes) - over 30 identified, required for autophagosome creation. LC3 (microtubule-associated protein light chain 3) - covalently linked to phosphatidylethanolamine (PE) via ubiquitin-like conjugation, PE-lipidated LC3 is a MARKER for autophagy and targets protein aggregates and damaged organelles. mTOR (mammalian target of rapamycin) - inhibited by nutrient deprivation - activates autophagy when inhibited. Beclin-1 - BCL2-interacting protein, key autophagy initiator. Rapamycin inhibits mTOR and induces autophagy.<br><br><b>Functions and Roles of Autophagy:</b> (1) Survival during nutrient deprivation (atrophic cells, starvation), (2) Turnover of organelles (ER, mitochondria via mitophagy, lysosomes), (3) Clearance of intracellular aggregates and effete organelles (quality control during aging and stress), (4) Host defense against intracellular microbes (xenophagy - autophagic vacuoles form around microbes in infected cells), (5) Extensive autophagy seen in ischemic injury and some myopathies. If stress overwhelms autophagy capacity, it can trigger APOPTOSIS as a last resort. Autophagy is selective - cargo loading targets protein aggregates and effete organelles via PE-lipidated LC3.<br><br><b>Dysregulation of Autophagy in Disease:</b> Cancer - cancer cells can acquire ability to survive without autophagy (autophagy also suppresses tumor initiation), Inflammatory bowel diseases (Crohn disease - ATG16L1 mutations), Neurodegenerative disorders (Alzheimer - clearance of tau and amyloid, Parkinson - PINK1/Parkin mitophagy pathway), Infections (mycobacteria evade xenophagy). Autophagy can be both tumor-suppressive (early) and tumor-promoting (late advanced stages).<br><br><b>QUICK COMPARISON: Necroptosis vs. Ferroptosis vs. Autophagy</b><br><br>Necroptosis: programmed necrosis, caspase-independent, RIPK1-RIPK3-MLKL pathway, triggered by TNFR1-Fas-viral sensors, morphology like necrosis, causes inflammation, backup anti-viral mechanism. Ferroptosis: iron-dependent, lipid peroxidation, overwhelms GPX4/glutathione defenses, resembles necrosis morphologically, distinctive EM - loss of mitochondrial cristae, ruptured outer mitochondrial membrane, prevented by iron chelation or antioxidants, linked to cancer-neurodegeneration-stroke. Autophagy: self-eating, survival mechanism, phagophore-autophagosome-autophagolysosome, LC3-PE as marker, ATG genes regulate it, primarily protective but can signal apoptosis if unresolved, dysregulated in cancer-IBD-neurodegeneration-infections. ANKIEOF echo "Exit code: $?"

wc -l /home/daytona/workspace/anki-cards/cell_death_pathology.txt && echo "---" && wc -c /home/daytona/workspace/anki-cards/cell_death_pathology.txt && echo "---" && grep -c $'\t' /home/daytona/workspace/anki-cards/cell_death_pathology.txt && echo "---" && python3 -c " with open('/home/daytona/workspace/anki-cards/cell_death_pathology.txt', 'r') as f: content = f.read() lines = content.split('\n') # filter blank trailing non_empty = [l for l in lines if l.strip()] print('Non-empty lines:', len(non_empty)) # Check for forbidden chars import re line = non_empty[0] if non_empty else '' parts = line.split('\t') print('Tab-separated parts:', len(parts)) print('Front (first 80 chars):', parts[0][:80] if parts else 'N/A') # Check for pipes and semicolons has_pipe = '|' in line has_newline_in_back = '\n' in (parts[1] if len(parts) > 1 else '') print('Has pipe:', has_pipe) print('Has newline in back:', has_newline_in_back) print('Back length (chars):', len(parts[1]) if len(parts) > 1 else 0) "

ls /home/daytona/workspace/anki-cards/ && wc -l /home/daytona/workspace/anki-cards/cell_death_pathology.txt && wc -c /home/daytona/workspace/anki-cards/cell_death_pathology.txt